Home » Healthcare » Pharmaceuticals » Nephrology Drugs Market

Nephrology Drugs Market By Type (Branded Nephrology Drugs, Generic Nephrology Drugs) By Product (Antihypertensive Medications, Erythropoiesis-Stimulating Agents (ESAs), Phosphate Binders, Immunosuppressants, Iron Supplements, Diuretics, Other Nephrology Medications) By Application (Chronic Kidney Disease (CKD), End-Stage Renal Disease (ESRD))- Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Price: $4999

Published: | Report ID: 22177 | Report Format : PDF

Market Insights

  • The global demand for nephrology drugs was valued at USD 16248.5 Million in 2022 and is expected to reach USD 25702.8 Million in 2030, growing at a CAGR of 5.9% between 2023 and 2030.
  • The antihypertensive medications category is expected to expand quickly in the forecast period, while the immunosuppressants segment has the greatest market share in 2022.
  • Chronic kidney disease (CKD) is the market leader in the application segment, accounting for more than 60% of total value in 2022, while the end-stage renal disease (ESRD) segment is estimated to grow rapidly in the projection period.
  • Branded nephrology drugs type dominate the global need for nephrology drugs, accounting for more than 58% in 2022 and are predicted to expand at a high CAGR.
  • The mid-range nephrology drugs price range category is expected to grow the fastest over the anticipated time frame, while low-cost nephrology drugs are expected to have a market share of more than 40% in 2022.
  • The hospital pharmacies category dominated the market with 35% of the total revenue share by distribution channel. In contrast, the specialized nephrology clinics category will expand fastest in the projected time frame.
  • With a significant market share of over 40% in 2022 and projections of high CAGR growth, the hospitals and clinics category will likely continue to dominate the demand for nephrology drugs globally.
  • North America is fueling the growth of the nephrology drugs industry with over one-third share in 2022, while Asia Pacific and Europe collectively account for just under 54% share in 2022. Europe held over 20% market revenue share in 2022.
  • The global need for dialysis and kidney transplants is expanding, boosting the demand for drugs to manage kidney diseases and support transplant patients.
  • The market is witnessing an increase in biologic drugs and biosimilars, offering alternatives to traditional nephrology medications, especially in the treatment of autoimmune kidney diseases.
  • Healthcare providers and pharmaceutical companies are increasingly emphasizing disease management and prevention strategies to slow the progression of kidney diseases, contributing to market growth.

nephrology drugs market (1)

Executive Summary

Market Definition

The nephrology drugs market refers to the segment of the pharmaceutical industry dedicated to the development, production, and distribution of medications and therapies designed to diagnose, manage, or treat various kidney-related conditions and diseases. These conditions can include chronic kidney disease (CKD), end-stage renal disease (ESRD), kidney transplant maintenance, autoimmune kidney disorders, and other nephrological disorders. Nephrology drugs encompass a wide range of pharmaceuticals, including immunosuppressants, diuretics, antihypertensives, erythropoietin-stimulating agents, and others, aimed at improving kidney function, preventing complications, and enhancing the quality of life for individuals with kidney-related health issues.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

Market Overview

The global nephrology drugs market has witnessed rapid growth in recent years and is expected to grow at a CAGR of 5.9% between 2023 and 2030. The market was valued at USD 16248.5 million in 2022 and is expected to reach USD 25702.8 million in 2030.

Nephrology is an area of medicine that studies the kidney and the disorders associated with it. Nephrology pharmaceuticals, also known as renal medicines, are administered by healthcare professionals for the treatment of various kidney disorders, such as kidney stones and infections, as well as to promote kidney health. These drugs can be used orally or intravenously.

The kidney is a key organ of the body. It is found in the abdominal cavity as a pair. Kidneys execute various vital tasks or life processes that keep the human body healthy. A kidney’s major purpose is to remove toxic waste, water, and undesirable substances from the body via the bloodstream. They serve as a filter for the human body. They are also in charge of the release of some important hormones. Kidneys regulate RBC production and fluid balance in the body. The internal field of medicine, known as nephrology, is concerned with the proper functioning of the kidney & its components, the overall and general well-being of the kidney, and the treatment of any renal diseases/disorders.

Nephrology pharmaceuticals are medications that help patients repair or treat their kidneys. Chronic kidney disorders, infections, stones, renal edema, nephrotic syndrome, kidney failure, and other conditions are treated using nephrology medications. They are also commonly utilized by dialysis patients. During the projection period, the rising prevalence of kidney illnesses would increase the demand for nephrology medications.

Segmentation by Type

  • The generic nephrology drugs segment is expected to exhibit the highest CAGR in the coming years. The affordability of generic options appeals to healthcare systems and patients alike, promoting their uptake.
  • Branded nephrology drugs dominate the market, accounting for over 58% of global demand in 2022. The trust and reliability associated with established brands maintain their market stronghold, particularly in critical applications.

Segmentation by Product

  • Immunosuppressants are the dominant product category, accounting for more than 25% of the global demand for nephrology drugs market in 2022 and are expected to grow at a high CAGR due to their critical role in kidney transplantations. Immunosuppressants play a pivotal major in preventing organ rejection in transplant patients, driving their demand.
  • The antihypertensive medications segment provides a less aggressive option for managing kidney diseases. Antihypertensive medications offer a more conservative approach, often used in the early stages of kidney disease and for controlling blood pressure.

Segmentation by Application

  • The end-stage renal disease (ESRD) segment is projected to register the highest CAGR. ESRD represents the most severe stage of kidney disease, necessitating immediate and intensive treatment.
  • Chronic kidney disease (CKD) currently leads the market with over 60% share in 2022. CKD is a widespread condition requiring continuous monitoring and treatment.

Segmentation by Price Range

  • The mid-range nephrology drugs segment is expected to post the highest CAGR during the forecasted period. Mid-range drugs provide a cost-effective option without compromising on efficacy.
  • Low-cost nephrology drugs led the market share with over 40% share in 2022. Low-cost drugs are crucial for ensuring access to treatment in economically challenged areas.

Segmentation by Distribution Channel

  • Specialized nephrology clinics are projected to exhibit the highest CAGR. Specialized clinics offer tailored care and expertise for patients with nephrological needs.
  • Hospital pharmacies currently dominate the market share, with over 35% in 2022 serving as essential points of access to nephrology drugs. Hospital pharmacies play a central role in providing immediate access to critical medications.

Segmentation by End User

  • The homecare patients segment is anticipated to register the highest CAGR, reflecting the growing trend of home-based care for managing kidney diseases. Homecare options promote patient comfort and reduce healthcare costs.
  • Hospitals and clinics segment is currently in the lead, with a market share of nearly 40% in 2022. Hospitals and clinics serve as primary centers for diagnosis and treatment.

Segmentation by Region

  • With its robust healthcare infrastructure and research capabilities, North America held over one-third of the global nephrology drugs market share in 2022, making it a highly lucrative region. The advanced regional healthcare systems and research institutions drive innovation and market growth.
  • Asia Pacific and Europe collectively contribute to nearly 54% of the market share, with the Asia Pacific region displaying potential for growth.
  • Europe’s substantial share of over 20% in the same year reflects its established medical facilities and robust market presence.
  • The rest of the world, encompassing regions like Latin America, the Middle East, and Africa, contributes to the remaining demand for nephrology drugs. These regions have unique healthcare challenges and growth prospects, offering opportunities for market expansion and development.

nephrology drugs market region (1)

The global nephrology drugs market growth is primarily driven by the elevating prevalence of kidney diseases, including CKD and ESRD, often linked to factors like hypertension, diabetes, and aging populations.

North America dominates the global nephrology drugs market primarily due to its robust healthcare infrastructure, extensive research capabilities, and a high prevalence of kidney-related diseases, notably chronic kidney disease (CKD) and end-stage renal disease (ESRD). As per the Centers for Disease Control & Prevention, CKD affects more than 20 million people in the U.S. every year. The well-established regional pharmaceutical sector and strong regulatory framework facilitate the development and approval of nephrology drugs. Moreover, a large aging population, along with a relatively high incidence of risk factors such as diabetes and hypertension, contributes to the elevated demand for nephrology medications. Healthcare reimbursement policies in North America support patient access to these drugs, further solidifying the regional dominance in the nephrology drugs industry.

Over the projection period, the Asia Pacific is estimated to be the fastest-growing market for nephrology drugs. The region has witnessed a rising prevalence of kidney-related diseases, fueled by factors like rising rates of diabetes and hypertension cases, along with lifestyle changes. Improving healthcare infrastructure, rising healthcare expenditure and greater access to healthcare services are also expanding the patient pool seeking nephrology treatments. Moreover, pharmaceutical companies are strategically expanding into the Asia Pacific, conducting clinical trials and customizing marketing approaches to tap into the rising demand for nephrology drugs. A growing awareness of kidney diseases and the adoption of telemedicine technologies are enhancing early detection and management, further boosting the need for nephrology medications in the region.

The increasing rate of chronic nephrology diseases, the rise in the number of kidney failure cases, the increase in the number of senior people, the expansion in need for diagnostic tests, the growth in cases of excessive alcohol consumption, and the rise in the number of obese people are all factors fueling the global demand for nephrology drugs.

Improvements in existing nephrology drugs products, as well as new product launches, are likely to fuel future nephrology drugs market revenue share growth. For example, in March 2022, Zydus Lifesciences Ltd, a drug manufacturer, announced Oxemia (Desidustat), a novel oral medication for the medical management of persistent kidney disease.

Key Highlights of the Report

The global nephrology drugs market is segmented by type, product, application, price range, distribution channel, end-user, and region. Generic nephrology drugs are expected to exhibit robust growth driven by cost-effectiveness. Branded nephrology drugs currently dominate the market, reflecting trust in established brands. Immunosuppressants, a critical product category, play a pivotal role in kidney transplantations. Chronic kidney disease (CKD) leads the market due to its prevalence, necessitating long-term management. Low-cost nephrology drugs cater to affordability, particularly in regions with limited healthcare resources. Specialized nephrology clinics are projected to exhibit strong growth, emphasizing the importance of tailored care.

A growth in the geriatric population, a rise in demand for diagnostic tests, a spike in excessive alcohol consumption, and an increase in obese people are some of the market drivers for nephrology drugs. The growth of the nephrology drugs industry is being driven by an upsurge in renal failure cases, an upward trend in dangerous changes in lifestyle, and chronic nephrology disorders. The nephrology drugs market is predicted to expand due to increased demand for targeted immunotherapies and advances in diagnosis and renal treatment. Increased R&D operations to develop pharmaceuticals, launch new products, and joint ventures and agreements between major market players are propelling the nephrology drugs market forward. Government activities for regulatory approvals and favorable insurance policies are likely to create good market expansion opportunities.

North America emerges as a prominent global market leader, driven by its robust healthcare infrastructure, extensive research capabilities, and a high prevalence of kidney-related diseases, notably CKD and ESRD. The well-established regional pharmaceutical industry and strong regulatory framework facilitate the development and approval of nephrology drugs. On the other hand, the Asia Pacific region presents substantial growth potential in the nephrology drugs market. This growth is propelled by several factors, including a rising prevalence of kidney-related diseases driven by changing demographics and increasing lifestyle-related risk factors. Moreover, escalating healthcare investments, improving access to healthcare services, and growing patient awareness in the Asia Pacific are contributing to the increased demand for nephrology drugs.

What Are The Main Drivers Of The Global Nephrology Drugs Market?

The main drivers of the global nephrology drugs market include the escalating prevalence of kidney diseases, particularly due to factors such as diabetes and hypertension, which are fueling the demand for medications to manage these conditions. Advancements in pharmaceutical research and development, leading to innovative drug therapies and biologics, are also propelling market growth. Moreover, the increasing number of kidney transplantations and the need for immunosuppressive drugs to prevent organ rejection, along with the expansion of healthcare infrastructure and rising healthcare investments in emerging markets, contribute to the market’s positive trajectory. Telemedicine integration and a growing focus on preventive care strategies are further augmenting the demand for nephrology drugs, aiming to improve patient outcomes and reduce the economic burden of kidney diseases.

What Are The Major Challenges Faced By The Global Nephrology Drugs Market?

The major challenges faced by the global nephrology drugs market include stringent regulatory requirements for drug approvals, particularly for complex biologic medications, which can lead to delays and increased development costs. The limited awareness of kidney diseases and delayed diagnosis, especially in underserved regions, limits early intervention and optimal treatment outcomes. Moreover, the emergence of drug-resistant strains of kidney-related pathogens, such as in cases of urinary tract infections, presents a key challenge. Furthermore, the higher cost of certain nephrology drugs and concerns regarding healthcare reimbursement policies in various regions hinder patient access to essential medications, affecting market growth.

What Are The Growth Opportunities In The Global Nephrology Drugs Market?

The global nephrology drugs market presents several growth opportunities, including the increasing focus on precision medicine and personalized therapies tailored to individual patient profiles, which leads to more effective treatments and improved outcomes. Moreover, the exploration of regenerative medicine and tissue engineering holds the potential for kidney regeneration and disease reversal, offering long-term treatment prospects. The expansion of healthcare infrastructure and investments in emerging markets, particularly in Asia, Latin America, and Africa, creates new avenues for market growth as awareness of kidney diseases grows. Furthermore, the integration of telemedicine and artificial intelligence tools in nephrology care can facilitate early disease detection and personalized treatment plans, enhancing patient care and expanding market reach.

Market Drivers

Several factors drive the global nephrology drugs market. The following are the key drivers of the global nephrology drugs market:

Increasing Prevalence of Chronic Kidney Disease (CKD)

The growing prevalence of CKD worldwide is a major driver of the nephrology drugs market expansion. For example, as per data collected by the National Kidney Foundation (NKF) in 2018, nearly 37 million people in the United States are impacted by renal disease each year, accounting for 15% of the population. Thus, nephrology medications are the first line of treatment recommended by healthcare specialists for controlling and preventing the spread of any serious kidney illness. CKD is a chronic and progressive condition characterized by the gradual loss of kidney function over time. It often develops as a result of underlying conditions such as hypertension, diabetes, and cardiovascular diseases. As these primary risk factors become more prevalent globally, the incidence of CKD has surged.

Moreover, lifestyle factors like poor dietary habits and sedentary lifestyles further contribute to the rise in CKD cases. This increasing disease burden fuels the demand for nephrology drugs, including those that manage blood pressure, control diabetes-related kidney complications, and address CKD-related anemia. Pharmaceutical companies respond to this escalating demand by developing and marketing drugs tailored to various stages and complications of CKD, propelling market revenue growth.

Market Restraints

The global nephrology drugs market faces challenges that may hinder its growth. These include the following:

Higher Cost of Medications

The high cost of many nephrology medications poses a key restraint on the global market. Kidney diseases often require long-term and sometimes lifelong treatment, which can result in substantial financial burdens for patients, especially in cases where medications are not fully covered by health insurance. Moreover, the cost of medications places strain on healthcare systems and budgets, limiting access to essential nephrology drugs for a significant portion of the population. This financial barrier can lead to delayed or inadequate treatment, potentially exacerbating kidney diseases and their associated complications. It also highlights the need for strategies to improve affordability and ensure equitable access to these vital medications, which remains a challenge in the nephrology drugs industry.

Opportunities

The global nephrology drugs market offers significant growth opportunities. These include the following:

Advancements in Telemedicine and Remote Patient Monitoring

The rapid expansion of telemedicine and remote patient monitoring presents a major market opportunity for nephrology drugs. Telehealth technologies, including video consultations, remote monitoring devices, and mobile health apps, enable healthcare providers to deliver care and monitor patients with kidney diseases remotely. This is especially beneficial for patients in underserved or remote areas, as it increases access to nephrology specialists and reduces the need for frequent in-person visits. These technologies facilitate early disease detection, medication management, and lifestyle interventions, ultimately improving patient outcomes. Pharmaceutical companies capitalize on this opportunity by developing drugs and therapies that integrate with telemedicine platforms, enhancing patient adherence and enabling healthcare providers to track treatment progress more effectively. As the adoption of telehealth continues to rise, this represents a promising avenue for growth and innovation in the nephrology drugs market.

Competitive Landscape

nephrology drugs market competitive (1)

Key Players

The global nephrology drugs market is highly competitive, characterized by the presence of several leading pharmaceutical companies and biotech firms striving for market dominance. The following are some of the top market players and their market shares:

  • AstraZeneca
  • Pfizer Inc
  • Amgen Inc
  • FibroGen Inc
  • GlaxoSmithKline Plc
  • AbbVie Inc
  • Akebia Therapeutics Inc
  • Teva Pharmaceutical Industries
  • Johnson & Johnson Inc
  • F. Hoffmann-La Roche
  • Others

These major players widely engage in strategic collaborations, mergers, and acquisitions to broaden their market share and strengthen their product portfolios. They also compete vigorously to launch novel drugs, gain regulatory approvals, and secure a strong market presence. Pricing strategies play a key role in market competition, with companies navigating the balance between affordability and profitability. The introduction of biosimilars and generic medications further intensifies competition, compelling companies to innovate and differentiate their offerings.

In January 2023, Boehringer Ingelheim and Eli Lilly & Company announced that the USFDA received a supplemental New Drug Application (sNDA) for Jardiance (empagliflozin) pills. The tablets are being studied as a potential medication to reduce the risk of renal disease progression and cardiovascular mortality in persons with chronic kidney disease (CKD).

In April 2019, Merck Sharp & Dohme Corp. received USFDA approval for its drug KEYTRUDA (pembrolizumab) for the management of renal cell carcinoma.

In March 2019, Janssen Pharmaceuticals Inc filed a supplemental New Drug Application (sNDA) with the USFDA Administration for canagliflozin, the first diabetic medication authorized for the management of chronic kidney disease in type 2 diabetes patients.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Summary of Key Findings

  • The aging global population contributes to the increasing incidence of kidney diseases, as the elderly are more susceptible to conditions like CKD and ESRD, driving market demand for nephrology drugs.
  • Market segmented by type, product, application, price range, distribution channel, end-user, and region.
  • Immunosuppressive drugs remain crucial for kidney transplant recipients to prevent organ rejection, and advancements in this segment are improving transplant success rates.
  • Ongoing R&D efforts are leading to innovative nephrology medications, including novel therapies for conditions like diabetic nephropathy and rare kidney diseases.
  • Patient-centric approaches in nephrology care, focusing on personalized treatment plans, are influencing drug development and market strategies.
  • Cost-containment measures in healthcare systems are driving the use of generic nephrology drugs and biosimilars to reduce treatment expenses.
  • Stringent regulatory requirements for drug approvals, especially for complex nephrology medications, pose challenges for manufacturers, potentially delaying market entry.

Future Outlook

  • Preventive measures, such as early detection and lifestyle modifications to manage risk factors like diabetes and hypertension, are gaining importance in kidney disease management, impacting drug utilization patterns.
  • Integration of telehealth and telemedicine into nephrology care enables remote consultations, monitoring, and prescription refills, improving access and convenience for patients.
  • The rising introduction of biosimilars in the nephrology drugs market is promoting price competition and expanding patient access to biologic therapies.
  • Value-based care models are shifting the focus towards improving patient outcomes, pushing drug manufacturers to demonstrate the effectiveness and cost-efficiency of nephrology medications.

Segmentation

  • By Type
    • Branded Nephrology Drugs
    • Generic Nephrology Drugs
  • By Product
    • Antihypertensive Medications
    • Erythropoiesis-Stimulating Agents (ESAs)
    • Phosphate Binders
    • Immunosuppressants
    • Iron Supplements
    • Diuretics
    • Other Nephrology Medications
  • By Application
    • Chronic Kidney Disease (CKD)
    • End-Stage Renal Disease (ESRD)
  • By Price Range
    • High-End Nephrology Drugs
    • Mid-Range Nephrology Drugs
    • Low-Cost Nephrology Drugs
  • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Specialized Nephrology Clinics
  • By End User
    • Hospitals and Clinics
    • Homecare Patients
    • Pharmaceutical Companies
  • By Region
    • North America
      • The U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • The U.K.
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
      • South-east Asia
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Argentina
      • Rest of Latin America
    • Middle East & Africa
      • GCC Countries
      • South Africa
      • Rest of the Middle East and Africa

Adjacent Markets

Several adjacent markets have high revenue growth opportunities in the nephrology drugs market. The key adjacent markets for nephrology drugs market –

nephrology drugs market adjacent (1)

1. Preface

1.1. Report Description

1.1.1. Purpose of the Report

1.1.2. Target Audience

1.1.3. USP and Key Offerings

1.2. Research Scope

1.3. Market Introduction

 

2. Executive Summary

2.1. Market Snapshot: Global Nephrology Drugs Market

2.1.1. Global Nephrology Drugs Market, By Type

2.1.2. Global Nephrology Drugs Market, By Product

2.1.3. Global Nephrology Drugs Market, By Application

2.1.4. Global Nephrology Drugs Market, By Price Range

2.1.5. Global Nephrology Drugs Market, By Distribution Channel

2.1.6. Global Nephrology Drugs Market, By End User

2.1.7. Global Nephrology Drugs Market, By Region

2.2. Insights from Primary Respondents

 

3. Market Dynamics & Factors Analysis

3.1. Introduction

3.1.1. Global Nephrology Drugs Market Value, 2017-2030, (US$ Mn)

3.1.2. Y-o-Y Growth Trend Analysis

3.2. Market Dynamics

3.2.1. Nephrology Drugs Market Drivers

3.2.2. Nephrology Drugs Market Restraints

3.2.3. Nephrology Drugs Market Opportunities

3.2.4. Major Nephrology Drugs Industry Challenges

3.3. Growth and Development Patterns

3.4. Investment Feasibility Analysis

3.5. Market Opportunity Analysis

3.5.1. Type

3.5.2. Product

3.5.3. Application

3.5.4. Price Range

3.5.5. Distribution Channel

3.5.6. End User

3.5.7. Geography

 

4. Market Competitive Landscape Analysis

4.1. Company Market Share Analysis, 2022

4.1.1. Global Nephrology Drugs Market: Company Market Share, Value 2022

4.1.2. Global Nephrology Drugs Market: Top 6 Company Market Share, Value 2022

4.1.3. Global Nephrology Drugs Market: Top 3 Company Market Share, Value 2022

4.2. Global Nephrology Drugs Market: Company Revenue Share Analysis, 2022

4.3. Company Assessment Metrics, 2022

4.3.1. Stars

4.3.2. Emerging Leaders

4.3.3. Pervasive Players

4.3.4. Participants

4.4. Startups/SMEs Assessment Metrics, 2022

4.4.1. Progressive Companies

4.4.2. Responsive Companies

4.4.3. Dynamic Companies

4.4.4. Starting Blocks

4.5. Strategic Development

4.5.1. Acquisition and Mergers

4.5.2. New Product Launch

4.5.3. Regional Expansion

4.5.4. Partnerships

4.6. Key Player Product Matrix

4.7. Potential for New Players in the Global Nephrology Drugs Market

 

5. Premium Insights

5.1. STAR (Situation, Task, Action, Results) Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Threat of New Entrants

5.2.2. Bargaining Power of Buyers/Consumers

5.2.3. Bargaining Power of Suppliers

5.2.4. Threat of Substitute Types

5.2.5. Intensity of Competitive Rivalry

5.3. PESTEL Analysis

5.3.1. Political Factors

5.3.2. Economic Factors

5.3.3. Social Factors

5.3.4. Technological Factors

5.3.5. Environmental Factors

5.3.6. Legal Factors

5.4. Key Market Trends

5.4.1. Demand Side Trends

5.4.2. Supply Side Trends

5.5. Value Chain Analysis

5.6. Technology Analysis

5.6.1. Research and development in the global market

5.6.2. Patent Analysis

5.6.3. Emerging technologies and their potential disruption to the market

5.7. Consumer Behaviour Analysis

5.7.1. Consumer Preferences and Expectations

5.7.2. Factors Influencing Consumer Buying Decisions

5.7.2.1. North America

5.7.2.2. Europe

5.7.2.3. Asia Pacific

5.7.2.4. Latin America

5.7.2.5. Middle East and Africa

5.7.3. Consumer Pain Points

5.8. Analysis and Recommendations

5.9. Adjacent Market Analysis

 

6. Market Positioning of Key Players, 2022

6.1. Company market share of key players, 2022

6.2. Competitive Benchmarking

6.3. Market Positioning of Key Vendors

6.4. Geographical Presence Analysis

6.5. Major Strategies Adopted by Key Players

6.5.1. Key Strategies Analysis

6.5.2. Mergers and Acquisitions

6.5.3. Partnerships

6.5.4. Product Launch

6.5.5. Geographical Expansion

6.5.6. Others

 

7. Impact Analysis of COVID-19 and Russia – Ukraine War on Nephrology Drugs Market

7.1. Ukraine-Russia War Impact

7.1.1. Uncertainty and Economic Instability

7.1.2. Supply chain disruptions

7.1.3. Regional market shifts

7.1.4. Shift in government priorities

7.2. COVID-19 Impact Analysis

7.2.1. Supply Chain Disruptions

7.2.2. Demand Fluctuations

7.2.3. Shift in Product Mix

7.2.4. Reduced Industrial Activity

7.2.5. Regional Impact Analysis

7.2.5.1. North America

7.2.5.2. Europe

7.2.5.3. Asia Pacific

7.2.5.4. Latin America

7.2.5.5. Middle East and Africa

 

8. Global Nephrology Drugs Market, By Type

8.1. Global Nephrology Drugs Market Overview, by Type

8.1.1. Global Nephrology Drugs Market Revenue Share, By Type, 2022 Vs 2030 (in %)

8.2. Branded Nephrology Drugs

8.2.1. Global Nephrology Drugs Market, By Branded Nephrology Drugs, By Region, 2017-2030 (US$ Mn)

8.2.2. Market Dynamics for Branded Nephrology Drugs

8.2.2.1. Drivers

8.2.2.2. Restraints

8.2.2.3. Opportunities

8.2.2.4. Trends

8.3. Generic Nephrology Drugs

8.3.1. Global Nephrology Drugs Market, By Generic Nephrology Drugs, By Region, 2017-2030 (US$ Mn)

8.3.2. Market Dynamics for Generic Nephrology Drugs

8.3.2.1. Drivers

8.3.2.2. Restraints

8.3.2.3. Opportunities

8.3.2.4. Trends

 

9. Global Nephrology Drugs Market, By Product

9.1. Global Nephrology Drugs Market Overview, by Product

9.1.1. Global Nephrology Drugs Market Revenue Share, By Product, 2022 Vs 2030 (in %)

9.2. Antihypertensive Medications

9.2.1. Global Nephrology Drugs Market, By Antihypertensive Medications, By Region, 2017-2030 (US$ Mn)

9.2.2. Market Dynamics for Antihypertensive Medications

9.2.2.1. Drivers

9.2.2.2. Restraints

9.2.2.3. Opportunities

9.2.2.4. Trends

9.3. Erythropoiesis-Stimulating Agents (ESAs)

9.3.1. Global Nephrology Drugs Market, By Erythropoiesis-Stimulating Agents (ESAs), By Region, 2017-2030 (US$ Mn)

9.3.2. Market Dynamics for Erythropoiesis-Stimulating Agents (ESAs)

9.3.2.1. Drivers

9.3.2.2. Restraints

9.3.2.3. Opportunities

9.3.2.4. Trends

9.4. Phosphate Binders

9.4.1. Global Nephrology Drugs Market, By Phosphate Binders, By Region, 2017-2030 (US$ Mn)

9.4.2. Market Dynamics for Phosphate Binders

9.4.2.1. Drivers

9.4.2.2. Restraints

9.4.2.3. Opportunities

9.4.2.4. Trends

9.5. Immunosuppressants

9.5.1. Global Nephrology Drugs Market, By Immunosuppressants, By Region, 2017-2030 (US$ Mn)

9.5.2. Market Dynamics for Immunosuppressants

9.5.2.1. Drivers

9.5.2.2. Restraints

9.5.2.3. Opportunities

9.5.2.4. Trends

9.6. Iron Supplements

9.6.1. Global Nephrology Drugs Market, By Iron Supplements, By Region, 2017-2030 (US$ Mn)

9.6.2. Market Dynamics for Iron Supplements

9.6.2.1. Drivers

9.6.2.2. Restraints

9.6.2.3. Opportunities

9.6.2.4. Trends

9.7. Diuretics

9.7.1. Global Nephrology Drugs Market, By Diuretics, By Region, 2017-2030 (US$ Mn)

9.7.2. Market Dynamics for Diuretics

9.7.2.1. Drivers

9.7.2.2. Restraints

9.7.2.3. Opportunities

9.7.2.4. Trends

9.8. Other Nephrology Medications

9.8.1. Global Nephrology Drugs Market, By Other Nephrology Medications, By Region, 2017-2030 (US$ Mn)

9.8.2. Market Dynamics for Other Nephrology Medications

9.8.2.1. Drivers

9.8.2.2. Restraints

9.8.2.3. Opportunities

9.8.2.4. Trends

 

10. Global Nephrology Drugs Market, By Application

10.1. Global Nephrology Drugs Market Overview, by Application

10.1.1. Global Nephrology Drugs Market Revenue Share, By Application, 2022 Vs 2030 (in %)

10.2. Chronic Kidney Disease (CKD)

10.2.1. Global Nephrology Drugs Market, By Chronic Kidney Disease (CKD), By Region, 2017-2030 (US$ Mn)

10.2.2. Market Dynamics for Chronic Kidney Disease (CKD)

10.2.2.1. Drivers

10.2.2.2. Restraints

10.2.2.3. Opportunities

10.2.2.4. Trends

10.3. End-Stage Renal Disease (ESRD)

10.3.1. Global Nephrology Drugs Market, By End-Stage Renal Disease (ESRD), By Region, 2017-2030 (US$ Mn)

10.3.2. Market Dynamics for End-Stage Renal Disease (ESRD)

10.3.2.1. Drivers

10.3.2.2. Restraints

10.3.2.3. Opportunities

10.3.2.4. Trends

 

11. Global Nephrology Drugs Market, By Price Range

11.1. Global Nephrology Drugs Market Overview, by Price Range

11.1.1. Global Nephrology Drugs Market Revenue Share, By Price Range, 2022 Vs 2030 (in %)

11.2. High-End Nephrology Drugs

11.2.1. Global Nephrology Drugs Market, By High-End Nephrology Drugs, By Region, 2017-2030 (US$ Mn)

11.2.2. Market Dynamics for High-End Nephrology Drugs

11.2.2.1. Drivers

11.2.2.2. Restraints

11.2.2.3. Opportunities

11.2.2.4. Trends

11.3. Mid-Range Nephrology Drugs

11.3.1. Global Nephrology Drugs Market, By Mid-Range Nephrology Drugs, By Region, 2017-2030 (US$ Mn)

11.3.2. Market Dynamics for Mid-Range Nephrology Drugs

11.3.2.1. Drivers

11.3.2.2. Restraints

11.3.2.3. Opportunities

11.3.2.4. Trends

11.4. Low-Cost Nephrology Drugs

11.4.1. Global Nephrology Drugs Market, By Low-Cost Nephrology Drugs, By Region, 2017-2030 (US$ Mn)

11.4.2. Market Dynamics for Low-Cost Nephrology Drugs

11.4.2.1. Drivers

11.4.2.2. Restraints

11.4.2.3. Opportunities

11.4.2.4. Trends

 

12. Global Nephrology Drugs Market, By Distribution Channel

12.1. Global Nephrology Drugs Market Overview, by Distribution Channel

12.1.1. Global Nephrology Drugs Market Revenue Share, By Distribution Channel, 2022 Vs 2030 (in %)

12.2. Hospital Pharmacies

12.2.1. Global Nephrology Drugs Market, By Hospital Pharmacies, By Region, 2017-2030 (US$ Mn)

12.2.2. Market Dynamics for Hospital Pharmacies

12.2.2.1. Drivers

12.2.2.2. Restraints

12.2.2.3. Opportunities

12.2.2.4. Trends

12.3. Retail Pharmacies

12.3.1. Global Nephrology Drugs Market, By Retail Pharmacies, By Region, 2017-2030 (US$ Mn)

12.3.2. Market Dynamics for Retail Pharmacies

12.3.2.1. Drivers

12.3.2.2. Restraints

12.3.2.3. Opportunities

12.3.2.4. Trends

12.4. Online Pharmacies

12.4.1. Global Nephrology Drugs Market, By Online Pharmacies, By Region, 2017-2030 (US$ Mn)

12.4.2. Market Dynamics for Online Pharmacies

12.4.2.1. Drivers

12.4.2.2. Restraints

12.4.2.3. Opportunities

12.4.2.4. Trends

12.5. Specialized Nephrology Clinics

12.5.1. Global Nephrology Drugs Market, By Specialized Nephrology Clinics, By Region, 2017-2030 (US$ Mn)

12.5.2. Market Dynamics for Specialized Nephrology Clinics

12.5.2.1. Drivers

12.5.2.2. Restraints

12.5.2.3. Opportunities

12.5.2.4. Trends

 

13. Global Nephrology Drugs Market, By End User

13.1. Global Nephrology Drugs Market Overview, by End User

13.1.1. Global Nephrology Drugs Market Revenue Share, By End User, 2022 Vs 2030 (in %)

13.2. Hospitals and Clinics

13.2.1. Global Nephrology Drugs Market, By Hospitals and Clinics, By Region, 2017-2030 (US$ Mn)

13.2.2. Market Dynamics for Hospitals and Clinics

13.2.2.1. Drivers

13.2.2.2. Restraints

13.2.2.3. Opportunities

13.2.2.4. Trends

13.3. Homecare Patients

13.3.1. Global Nephrology Drugs Market, By Homecare Patients, By Region, 2017-2030 (US$ Mn)

13.3.2. Market Dynamics for Homecare Patients

13.3.2.1. Drivers

13.3.2.2. Restraints

13.3.2.3. Opportunities

13.3.2.4. Trends

13.4. Pharmaceutical Companies

13.4.1. Global Nephrology Drugs Market, By Pharmaceutical Companies, By Region, 2017-2030 (US$ Mn)

13.4.2. Market Dynamics for Pharmaceutical Companies

13.4.2.1. Drivers

13.4.2.2. Restraints

13.4.2.3. Opportunities

13.4.2.4. Trends

 

14. Global Nephrology Drugs Market, By Region

14.1. Global Nephrology Drugs Market Overview, by Region

14.1.1. Global Nephrology Drugs Market, By Region, 2022 vs 2030 (in%)

14.2. Type

14.2.1. Global Nephrology Drugs Market, By Type, 2017-2030 (US$ Mn)

14.3. Product

14.3.1. Global Nephrology Drugs Market, By Product, 2017-2030 (US$ Mn)

14.4. Application

14.4.1. Global Nephrology Drugs Market, By Application, 2017-2030 (US$ Mn)

14.5. Price Range

14.5.1. Global Nephrology Drugs Market, By Price Range, 2017-2030 (US$ Mn)

14.6. Distribution Channel

14.6.1. Global Nephrology Drugs Market, By Distribution Channel, 2017-2030 (US$ Mn)

14.7. End User

14.7.1. Global Nephrology Drugs Market, By End User, 2017-2030 (US$ Mn)

 

15. North America Nephrology Drugs Market Analysis

15.1. Overview

15.1.1. Market Dynamics for North America

15.1.1.1. Drivers

15.1.1.2. Restraints

15.1.1.3. Opportunities

15.1.1.4. Trends

15.2. North America Nephrology Drugs Market, by Type, 2017-2030(US$ Mn)

15.2.1. Overview

15.2.2. SRC Analysis

15.3. North America Nephrology Drugs Market, by Product, 2017-2030(US$ Mn)

15.3.1. Overview

15.3.2. SRC Analysis

15.4. North America Nephrology Drugs Market, by Application, 2017-2030(US$ Mn)

15.4.1. Overview

15.4.2. SRC Analysis

15.5. North America Nephrology Drugs Market, by Price Range, 2017-2030(US$ Mn)

15.5.1. Overview

15.5.2. SRC Analysis

15.6. North America Nephrology Drugs Market, by Distribution Channel, 2017-2030(US$ Mn)

15.6.1. Overview

15.6.2. SRC Analysis

15.7. North America Nephrology Drugs Market, by End User, 2017-2030(US$ Mn)

15.7.1. Overview

15.7.2. SRC Analysis

15.8. North America Nephrology Drugs Market, by Country, 2017-2030 (US$ Mn)

15.8.1. North America Nephrology Drugs Market, by Country, 2022 Vs 2030 (in%)

15.8.2. U.S.

15.8.3. Canada

15.8.4. Mexico

 

16. Europe Nephrology Drugs Market Analysis

16.1. Overview

16.1.1. Market Dynamics for North America

16.1.1.1. Drivers

16.1.1.2. Restraints

16.1.1.3. Opportunities

16.1.1.4. Trends

16.2. Europe Nephrology Drugs Market, by Type, 2017-2030(US$ Mn)

16.2.1. Overview

16.2.2. SRC Analysis

16.3. Europe Nephrology Drugs Market, by Product, 2017-2030(US$ Mn)

16.3.1. Overview

16.3.2. SRC Analysis

16.4. Europe Nephrology Drugs Market, by Application, 2017-2030(US$ Mn)

16.4.1. Overview

16.4.2. SRC Analysis

16.5. Europe Nephrology Drugs Market, by Price Range, 2017-2030(US$ Mn)

16.5.1. Overview

16.5.2. SRC Analysis

16.6. Europe Nephrology Drugs Market, by Distribution Channel, 2017-2030(US$ Mn)

16.6.1. Overview

16.6.2. SRC Analysis

16.7. Europe Nephrology Drugs Market, by End User, 2017-2030(US$ Mn)

16.7.1. Overview

16.7.2. SRC Analysis

16.8. Europe Nephrology Drugs Market, by Country, 2017-2030 (US$ Mn)

16.8.1. Europe Nephrology Drugs Market, by Country, 2022 Vs 2030 (in%)

16.8.2. UK

16.8.3. France

16.8.4. Germany

16.8.5. Italy

16.8.6. Spain

16.8.7. Benelux

16.8.8. Russia

16.8.9. Rest of Europe

 

17. Asia Pacific Nephrology Drugs Market Analysis

17.1. Overview

17.1.1. Market Dynamics for North America

17.1.1.1. Drivers

17.1.1.2. Restraints

17.1.1.3. Opportunities

17.1.1.4. Trends

17.2. Asia Pacific Nephrology Drugs Market, by Type, 2017-2030(US$ Mn)

17.2.1. Overview

17.2.2. SRC Analysis

17.3. Asia Pacific Nephrology Drugs Market, by Product, 2017-2030(US$ Mn)

17.3.1. Overview

17.3.2. SRC Analysis

17.4. Asia Pacific Nephrology Drugs Market, by Application, 2017-2030(US$ Mn)

17.4.1. Overview

17.4.2. SRC Analysis

17.5. Asia Pacific Nephrology Drugs Market, by Price Range, 2017-2030(US$ Mn)

17.5.1. Overview

17.5.2. SRC Analysis

17.6. Asia Pacific Nephrology Drugs Market, by Distribution Channel, 2017-2030(US$ Mn)

17.6.1. Overview

17.6.2. SRC Analysis

17.7. Asia Pacific Nephrology Drugs Market, by End User, 2017-2030(US$ Mn)

17.7.1. Overview

17.7.2. SRC Analysis

17.8. Asia Pacific Nephrology Drugs Market, by Country, 2017-2030 (US$ Mn)

17.8.1. Asia Pacific Nephrology Drugs Market, by Country, 2022 Vs 2030 (in%)

17.8.2. China

17.8.3. Japan

17.8.4. India

17.8.5. South Korea

17.8.6. South East Asia

17.8.7. Rest of Asia Pacific

 

18. Latin America Nephrology Drugs Market Analysis

18.1. Overview

18.1.1. Market Dynamics for North America

18.1.1.1. Drivers

18.1.1.2. Restraints

18.1.1.3. Opportunities

18.1.1.4. Trends

18.2. Latin America Nephrology Drugs Market, by Type, 2017-2030(US$ Mn)

18.2.1. Overview

18.2.2. SRC Analysis

18.3. Latin America Nephrology Drugs Market, by Product, 2017-2030(US$ Mn)

18.3.1. Overview

18.3.2. SRC Analysis

18.4. Latin America Nephrology Drugs Market, by Application, 2017-2030(US$ Mn)

18.4.1. Overview

18.4.2. SRC Analysis

18.5. Latin America Nephrology Drugs Market, by Price Range, 2017-2030(US$ Mn)

18.5.1. Overview

18.5.2. SRC Analysis

18.6. Latin America Nephrology Drugs Market, by Distribution Channel, 2017-2030(US$ Mn)

18.6.1. Overview

18.6.2. SRC Analysis

18.7. Latin America Nephrology Drugs Market, by End User, 2017-2030(US$ Mn)

18.7.1. Overview

18.7.2. SRC Analysis

18.8. Latin America Nephrology Drugs Market, by Country, 2017-2030 (US$ Mn)

18.8.1. Latin America Nephrology Drugs Market, by Country, 2022 Vs 2030 (in%)

18.8.2. Brazil

18.8.3. Argentina

18.8.4. Rest of Latin America

 

19. Middle East Nephrology Drugs Market Analysis

19.1. Overview

19.1.1. Market Dynamics for North America

19.1.1.1. Drivers

19.1.1.2. Restraints

19.1.1.3. Opportunities

19.1.1.4. Trends

19.2. Middle East Nephrology Drugs Market, by Type, 2017-2030(US$ Mn)

19.2.1. Overview

19.2.2. SRC Analysis

19.3. Middle East Nephrology Drugs Market, by Product, 2017-2030(US$ Mn)

19.3.1. Overview

19.3.2. SRC Analysis

19.4. Middle East Nephrology Drugs Market, by Application, 2017-2030(US$ Mn)

19.4.1. Overview

19.4.2. SRC Analysis

19.5. Middle East Nephrology Drugs Market, by Price Range, 2017-2030(US$ Mn)

19.5.1. Overview

19.5.2. SRC Analysis

19.6. Middle East Nephrology Drugs Market, by Distribution Channel, 2017-2030(US$ Mn)

19.6.1. Overview

19.6.2. SRC Analysis

19.7. Middle East Nephrology Drugs Market, by End User, 2017-2030(US$ Mn)

19.7.1. Overview

19.7.2. SRC Analysis

19.8. Middle East Nephrology Drugs Market, by Country, 2017-2030 (US$ Mn)

19.8.1. Middle East Nephrology Drugs Market, by Country, 2022 Vs 2030 (in%)

19.8.2. UAE

19.8.3. Saudi Arabia

19.8.4. Rest of Middle East

 

20. Africa Nephrology Drugs Market Analysis

20.1. Overview

20.1.1. Market Dynamics for North America

20.1.1.1. Drivers

20.1.1.2. Restraints

20.1.1.3. Opportunities

20.1.1.4. Trends

20.2. Africa Nephrology Drugs Market, by Type, 2017-2030(US$ Mn)

20.2.1. Overview

20.2.2. SRC Analysis

20.3. Africa Nephrology Drugs Market, by Product, 2017-2030(US$ Mn)

20.3.1. Overview

20.3.2. SRC Analysis

20.4. Africa Nephrology Drugs Market, by Application, 2017-2030(US$ Mn)

20.4.1. Overview

20.4.2. SRC Analysis

20.5. Africa Nephrology Drugs Market, by Price Range, 2017-2030(US$ Mn)

20.5.1. Overview

20.5.2. SRC Analysis

20.6. Africa Nephrology Drugs Market, by Distribution Channel, 2017-2030(US$ Mn)

20.6.1. Overview

20.6.2. SRC Analysis

20.7. Africa Nephrology Drugs Market, by End User, 2017-2030(US$ Mn)

20.7.1. Overview

20.7.2. SRC Analysis

20.8. Africa Nephrology Drugs Market, by Country, 2017-2030 (US$ Mn)

20.8.1. Middle East Nephrology Drugs Market, by Country, 2022 Vs 2030 (in%)

20.8.2. South Africa

20.8.3. Egypt

20.8.4. Rest of Africa

 

21. Company Profiles

21.1. AstraZeneca

21.1.1. Company Overview

21.1.2. Products/Services Portfolio

21.1.3. Geographical Presence

21.1.4. SWOT Analysis

21.1.5. Financial Summary

21.1.5.1. Market Revenue and Net Profit (2019-2022)

21.1.5.2. Business Segment Revenue Analysis

21.1.5.3. Geographical Revenue Analysis

21.2. Pfizer Inc

21.3. Amgen Inc

21.4. FibroGen Inc

21.5. GlaxoSmithKline Plc

21.6. AbbVie Inc

21.7. Akebia Therapeutics Inc

21.8. Teva Pharmaceutical Industries

21.9. Johnson & Johnson Inc

21.10. F. Hoffmann-La Roche

21.11. Others

 

22. Research Methodology

22.1. Research Methodology

22.2. Phase I – Secondary Research

22.3. Phase II – Data Modelling

22.3.1. Company Share Analysis Model

22.3.2. Revenue Based Modelling

22.4. Phase III – Primary Research

22.5. Research Limitations

22.5.1. Assumptions

 

List of Figures

FIG. 1 Global Nephrology Drugs Market: Research Methodology

FIG. 2 Market Size Estimation – Top Down & Bottom Up Approach

FIG. 3 Global Nephrology Drugs Market Segmentation

FIG. 4 Global Nephrology Drugs Market, by Type, 2022 (US$ Mn)

FIG. 5 Global Nephrology Drugs Market, by Product, 2022 (US$ Mn)

FIG. 6 Global Nephrology Drugs Market, by Application, 2022 (US$ Mn)

FIG. 7 Global Nephrology Drugs Market, by Price Range, 2022 (US$ Mn)

FIG. 8 Global Nephrology Drugs Market, by Distribution Channel, 2022 (US$ Mn)

FIG. 9 Global Nephrology Drugs Market, by End User, 2022 (US$ Mn)

FIG. 10 Global Nephrology Drugs Market, by Geography, 2022 (US$ Mn)

FIG. 11 Attractive Investment Proposition, by Type, 2022

FIG. 12 Attractive Investment Proposition, by Product, 2022

FIG. 13 Attractive Investment Proposition, by Application, 2022

FIG. 14 Attractive Investment Proposition, by Price Range, 2022

FIG. 15 Attractive Investment Proposition, by Distribution Channel, 2022

FIG. 16 Attractive Investment Proposition, by End User, 2022

FIG. 17 Attractive Investment Proposition, by Geography, 2022

FIG. 18 Global Market Share Analysis of Key Nephrology Drugs Market Manufacturers, 2022

FIG. 19 Global Market Positioning of Key Nephrology Drugs Market Manufacturers, 2022

FIG. 20 Global Nephrology Drugs Market Value Contribution, By Type, 2022 & 2030 (Value %)

FIG. 21 Global Nephrology Drugs Market, by Branded Nephrology Drugs, Value, 2017-2030 (US$ Mn)

FIG. 22 Global Nephrology Drugs Market, by Generic Nephrology Drugs, Value, 2017-2030 (US$ Mn)

FIG. 23 Global Nephrology Drugs Market Value Contribution, By Product, 2022 & 2030 (Value %)

FIG. 24 Global Nephrology Drugs Market, by Antihypertensive Medications, Value, 2017-2030 (US$ Mn)

FIG. 25 Global Nephrology Drugs Market, by Erythropoiesis-Stimulating Agents (ESAs), Value, 2017-2030 (US$ Mn)

FIG. 26 Global Nephrology Drugs Market, by Phosphate Binders, Value, 2017-2030 (US$ Mn)

FIG. 27 Global Nephrology Drugs Market, by Immunosuppressants, Value, 2017-2030 (US$ Mn)

FIG. 28 Global Nephrology Drugs Market, by Iron Supplements, Value, 2017-2030 (US$ Mn)

FIG. 29 Global Nephrology Drugs Market, by Diuretics, Value, 2017-2030 (US$ Mn)

FIG. 30 Global Nephrology Drugs Market, by Other Nephrology Medications, Value, 2017-2030 (US$ Mn)

FIG. 31 Global Nephrology Drugs Market Value Contribution, By Application, 2022 & 2030 (Value %)

FIG. 32 Global Nephrology Drugs Market, by Chronic Kidney Disease (CKD), Value, 2017-2030 (US$ Mn)

FIG. 33 Global Nephrology Drugs Market, by End-Stage Renal Disease (ESRD), Value, 2017-2030 (US$ Mn)

FIG. 34 Global Nephrology Drugs Market Value Contribution, By Price Range, 2022 & 2030 (Value %)

FIG. 35 Global Nephrology Drugs Market, by High-End Nephrology Drugs, Value, 2017-2030 (US$ Mn)

FIG. 36 Global Nephrology Drugs Market, by Mid-Range Nephrology Drugs, Value, 2017-2030 (US$ Mn)

FIG. 37 Global Nephrology Drugs Market, by Low-Cost Nephrology Drugs, Value, 2017-2030 (US$ Mn)

FIG. 38 Global Nephrology Drugs Market Value Contribution, By Distribution Channel, 2022 & 2030 (Value %)

FIG. 39 Global Nephrology Drugs Market, by Hospital Pharmacies, Value, 2017-2030 (US$ Mn)

FIG. 40 Global Nephrology Drugs Market, by Retail Pharmacies, Value, 2017-2030 (US$ Mn)

FIG. 41 Global Nephrology Drugs Market, by Online Pharmacies, Value, 2017-2030 (US$ Mn)

FIG. 42 Global Nephrology Drugs Market, by Specialized Nephrology Clinics, Value, 2017-2030 (US$ Mn)

FIG. 43 Global Nephrology Drugs Market Value Contribution, By End User, 2022 & 2030 (Value %)

FIG. 44 Global Nephrology Drugs Market, by Hospitals and Clinics, Value, 2017-2030 (US$ Mn)

FIG. 45 Global Nephrology Drugs Market, by Homecare Patients, Value, 2017-2030 (US$ Mn)

FIG. 46 Global Nephrology Drugs Market, by Pharmaceutical Companies, Value, 2017-2030 (US$ Mn)

FIG. 47 North America Nephrology Drugs Market, 2017-2030 (US$ Mn)

FIG. 48 U.S. Nephrology Drugs Market, 2017-2030 (US$ Mn)

FIG. 49 Canada Nephrology Drugs Market, 2017-2030 (US$ Mn)

FIG. 50 Mexico Nephrology Drugs Market, 2017-2030 (US$ Mn)

FIG. 51 Europe Nephrology Drugs Market, 2017-2030 (US$ Mn)

FIG. 52 Germany Nephrology Drugs Market, 2017-2030 (US$ Mn)

FIG. 53 France Nephrology Drugs Market, 2017-2030 (US$ Mn)

FIG. 54 U.K. Nephrology Drugs Market, 2017-2030 (US$ Mn)

FIG. 55 Italy Nephrology Drugs Market, 2017-2030 (US$ Mn)

FIG. 56 Spain Nephrology Drugs Market, 2017-2030 (US$ Mn)

FIG. 57 Benelux Nephrology Drugs Market, 2017-2030 (US$ Mn)

FIG. 58 Russia Nephrology Drugs Market, 2017-2030 (US$ Mn)

FIG. 59 Rest of Europe Nephrology Drugs Market, 2017-2030 (US$ Mn)

FIG. 60 Asia Pacific Nephrology Drugs Market, 2017-2030 (US$ Mn)

FIG. 61 China Nephrology Drugs Market, 2017-2030 (US$ Mn)

FIG. 62 Japan Nephrology Drugs Market, 2017-2030 (US$ Mn)

FIG. 63 India Nephrology Drugs Market, 2017-2030 (US$ Mn)

FIG. 64 South Korea Nephrology Drugs Market, 2017-2030 (US$ Mn)

FIG. 65 South-East Asia Nephrology Drugs Market, 2017-2030 (US$ Mn)

FIG. 66 Rest of Asia Pacific Nephrology Drugs Market, 2017-2030 (US$ Mn)

FIG. 67 Latin America Nephrology Drugs Market, 2017-2030 (US$ Mn)

FIG. 68 Brazil Nephrology Drugs Market, 2017-2030 (US$ Mn)

FIG. 69 Argentina Nephrology Drugs Market, 2017-2030 (US$ Mn)

FIG. 70 Rest of Latin America Nephrology Drugs Market, 2017-2030 (US$ Mn)

FIG. 71 Middle East Nephrology Drugs Market, 2017-2030 (US$ Mn)

FIG. 72 UAE Nephrology Drugs Market, 2017-2030 (US$ Mn)

FIG. 73 Saudi Arabia Nephrology Drugs Market, 2017-2030 (US$ Mn)

FIG. 74 Rest of Middle East Nephrology Drugs Market, 2017-2030 (US$ Mn)

FIG. 75 Africa Nephrology Drugs Market, 2017-2030 (US$ Mn)

FIG. 76 South Africa Nephrology Drugs Market, 2017-2030 (US$ Mn)

FIG. 77 Egypt Nephrology Drugs Market, 2017-2030 (US$ Mn)

FIG. 78 Rest of Africa Nephrology Drugs Market, 2017-2030 (US$ Mn)

 

List of Tables

TABLE 1 Market Snapshot: Global Nephrology Drugs Market

TABLE 2 Global Nephrology Drugs Market: Market Drivers Impact Analysis

TABLE 3 Global Nephrology Drugs Market: Market Restraints Impact Analysis

TABLE 4 Global Nephrology Drugs Market, by Competitive Benchmarking, 2022

TABLE 5 Global Nephrology Drugs Market, by Geographical Presence Analysis, 2022

TABLE 6 Global Nephrology Drugs Market, by Key Strategies Analysis, 2022

TABLE 7 Global Nephrology Drugs Market, by Branded Nephrology Drugs, By Region, 2017-2022 (US$ Mn)

TABLE 8 Global Nephrology Drugs Market, by Branded Nephrology Drugs, By Region, 2023-2030 (US$ Mn)

TABLE 9 Global Nephrology Drugs Market, by Generic Nephrology Drugs, By Region, 2017-2022 (US$ Mn)

TABLE 10 Global Nephrology Drugs Market, by Generic Nephrology Drugs, By Region, 2023-2030 (US$ Mn)

TABLE 11 Global Nephrology Drugs Market, by Antihypertensive Medications, By Region, 2017-2022 (US$ Mn)

TABLE 12 Global Nephrology Drugs Market, by Antihypertensive Medications, By Region, 2023-2030 (US$ Mn)

TABLE 13 Global Nephrology Drugs Market, by Erythropoiesis-Stimulating Agents (ESAs), By Region, 2017-2022 (US$ Mn)

TABLE 14 Global Nephrology Drugs Market, by Erythropoiesis-Stimulating Agents (ESAs), By Region, 2023-2030 (US$ Mn)

TABLE 15 Global Nephrology Drugs Market, by Phosphate Binders, By Region, 2017-2022 (US$ Mn)

TABLE 16 Global Nephrology Drugs Market, by Phosphate Binders, By Region, 2023-2030 (US$ Mn)

TABLE 17 Global Nephrology Drugs Market, by Immunosuppressants, By Region, 2017-2022 (US$ Mn)

TABLE 18 Global Nephrology Drugs Market, by Immunosuppressants, By Region, 2023-2030 (US$ Mn)

TABLE 19 Global Nephrology Drugs Market, by Iron Supplements, By Region, 2017-2022 (US$ Mn)

TABLE 20 Global Nephrology Drugs Market, by Iron Supplements, By Region, 2023-2030 (US$ Mn)

TABLE 21 Global Nephrology Drugs Market, by Diuretics, By Region, 2017-2022 (US$ Mn)

TABLE 22 Global Nephrology Drugs Market, by Diuretics, By Region, 2023-2030 (US$ Mn)

TABLE 23 Global Nephrology Drugs Market, by Other Nephrology Medications, By Region, 2017-2022 (US$ Mn)

TABLE 24 Global Nephrology Drugs Market, by Other Nephrology Medications, By Region, 2023-2030 (US$ Mn)

TABLE 25 Global Nephrology Drugs Market, by Chronic Kidney Disease (CKD), By Region, 2017-2022 (US$ Mn)

TABLE 26 Global Nephrology Drugs Market, by Chronic Kidney Disease (CKD), By Region, 2023-2030 (US$ Mn)

TABLE 27 Global Nephrology Drugs Market, by End-Stage Renal Disease (ESRD), By Region, 2017-2022 (US$ Mn)

TABLE 28 Global Nephrology Drugs Market, by End-Stage Renal Disease (ESRD), By Region, 2023-2030 (US$ Mn)

TABLE 29 Global Nephrology Drugs Market, by High-End Nephrology Drugs, By Region, 2017-2022 (US$ Mn)

TABLE 30 Global Nephrology Drugs Market, by High-End Nephrology Drugs, By Region, 2023-2030 (US$ Mn)

TABLE 31 Global Nephrology Drugs Market, by Mid-Range Nephrology Drugs, By Region, 2017-2022 (US$ Mn)

TABLE 32 Global Nephrology Drugs Market, by Mid-Range Nephrology Drugs, By Region, 2023-2030 (US$ Mn)

TABLE 33 Global Nephrology Drugs Market, by Low-Cost Nephrology Drugs, By Region, 2017-2022 (US$ Mn)

TABLE 34 Global Nephrology Drugs Market, by Low-Cost Nephrology Drugs, By Region, 2023-2030 (US$ Mn)

TABLE 35 Global Nephrology Drugs Market, by Hospital Pharmacies, By Region, 2017-2022 (US$ Mn)

TABLE 36 Global Nephrology Drugs Market, by Hospital Pharmacies, By Region, 2023-2030 (US$ Mn)

TABLE 37 Global Nephrology Drugs Market, by Retail Pharmacies, By Region, 2017-2022 (US$ Mn)

TABLE 38 Global Nephrology Drugs Market, by Retail Pharmacies, By Region, 2023-2030 (US$ Mn)

TABLE 39 Global Nephrology Drugs Market, by Online Pharmacies, By Region, 2017-2022 (US$ Mn)

TABLE 40 Global Nephrology Drugs Market, by Online Pharmacies, By Region, 2023-2030 (US$ Mn)

TABLE 41 Global Nephrology Drugs Market, by Specialized Nephrology Clinics, By Region, 2017-2022 (US$ Mn)

TABLE 42 Global Nephrology Drugs Market, by Specialized Nephrology Clinics, By Region, 2023-2030 (US$ Mn)

TABLE 43 Global Nephrology Drugs Market, by Hospitals and Clinics, By Region, 2017-2022 (US$ Mn)

TABLE 44 Global Nephrology Drugs Market, by Hospitals and Clinics, By Region, 2023-2030 (US$ Mn)

TABLE 45 Global Nephrology Drugs Market, by Homecare Patients, By Region, 2017-2022 (US$ Mn)

TABLE 46 Global Nephrology Drugs Market, by Homecare Patients, By Region, 2023-2030 (US$ Mn)

TABLE 47 Global Nephrology Drugs Market, by Pharmaceutical Companies, By Region, 2017-2022 (US$ Mn)

TABLE 48 Global Nephrology Drugs Market, by Pharmaceutical Companies, By Region, 2023-2030 (US$ Mn)

TABLE 49 Global Nephrology Drugs Market, by Type, 2017-2022 (US$ Mn)

TABLE 50 Global Nephrology Drugs Market, by Type, 2023-2030 (US$ Mn)

TABLE 51 Global Nephrology Drugs Market, by Product, 2017-2022 (US$ Mn)

TABLE 52 Global Nephrology Drugs Market, by Product, 2023-2030 (US$ Mn)

TABLE 53 Global Nephrology Drugs Market, by Application, 2017-2022 (US$ Mn)

TABLE 54 Global Nephrology Drugs Market, by Application, 2023-2030 (US$ Mn)

TABLE 55 Global Nephrology Drugs Market, by Price Range, By Region, 2017-2022 (US$ Mn)

TABLE 56 Global Nephrology Drugs Market, by Price Range, By Region, 2023-2030 (US$ Mn)

TABLE 57 Global Nephrology Drugs Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 58 Global Nephrology Drugs Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 59 Global Nephrology Drugs Market, by End User, 2017-2022 (US$ Mn)

TABLE 60 Global Nephrology Drugs Market, by End User, 2023-2030 (US$ Mn)

TABLE 61 Global Nephrology Drugs Market, by Region, 2017-2022 (US$ Mn)

TABLE 62 Global Nephrology Drugs Market, by Region, 2023-2030 (US$ Mn)

TABLE 63 North America Nephrology Drugs Market, by Type, 2017-2022 (US$ Mn)

TABLE 64 North America Nephrology Drugs Market, by Type, 2023-2030 (US$ Mn)

TABLE 65 North America Nephrology Drugs Market, by Product, 2017-2022 (US$ Mn)

TABLE 66 North America Nephrology Drugs Market, by Product, 2023-2030 (US$ Mn)

TABLE 67 North America Nephrology Drugs Market, by Application, 2017-2022 (US$ Mn)

TABLE 68 North America Nephrology Drugs Market, by Application, 2023-2030 (US$ Mn)

TABLE 69 North America Nephrology Drugs Market, by Price Range, By Region, 2017-2022 (US$ Mn)

TABLE 70 North America Nephrology Drugs Market, by Price Range, By Region, 2023-2030 (US$ Mn)

TABLE 71 North America Nephrology Drugs Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 72 North America Nephrology Drugs Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 73 North America Nephrology Drugs Market, by End User, 2017-2022 (US$ Mn)

TABLE 74 North America Nephrology Drugs Market, by End User, 2023-2030 (US$ Mn)

TABLE 75 North America Nephrology Drugs Market, by Country, 2017-2022 (US$ Mn)

TABLE 76 North America Nephrology Drugs Market, by Country, 2023-2030 (US$ Mn)

TABLE 77 United States Nephrology Drugs Market, by Type, 2017-2022 (US$ Mn)

TABLE 78 United States Nephrology Drugs Market, by Type, 2023-2030 (US$ Mn)

TABLE 79 United States Nephrology Drugs Market, by Product, 2017-2022 (US$ Mn)

TABLE 80 United States Nephrology Drugs Market, by Product, 2023-2030 (US$ Mn)

TABLE 81 United States Nephrology Drugs Market, by Application, 2017-2022 (US$ Mn)

TABLE 82 United States Nephrology Drugs Market, by Application, 2023-2030 (US$ Mn)

TABLE 83 United States Nephrology Drugs Market, by Price Range, By Region, 2017-2022 (US$ Mn)

TABLE 84 United States Nephrology Drugs Market, by Price Range, By Region, 2023-2030 (US$ Mn)

TABLE 85 United States Nephrology Drugs Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 86 United States Nephrology Drugs Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 87 United States Nephrology Drugs Market, by End User, 2017-2022 (US$ Mn)

TABLE 88 United States Nephrology Drugs Market, by End User, 2023-2030 (US$ Mn)

TABLE 89 Canada Nephrology Drugs Market, by Type, 2017-2022 (US$ Mn)

TABLE 90 Canada Nephrology Drugs Market, by Type, 2023-2030 (US$ Mn)

TABLE 91 Canada Nephrology Drugs Market, by Product, 2017-2022 (US$ Mn)

TABLE 92 Canada Nephrology Drugs Market, by Product, 2023-2030 (US$ Mn)

TABLE 93 Canada Nephrology Drugs Market, by Application, 2017-2022 (US$ Mn)

TABLE 94 Canada Nephrology Drugs Market, by Application, 2023-2030 (US$ Mn)

TABLE 95 Canada Nephrology Drugs Market, by Price Range, By Region, 2017-2022 (US$ Mn)

TABLE 96 Canada Nephrology Drugs Market, by Price Range, By Region, 2023-2030 (US$ Mn)

TABLE 97 Canada Nephrology Drugs Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 98 Canada Nephrology Drugs Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 99 Canada Nephrology Drugs Market, by End User, 2017-2022 (US$ Mn)

TABLE 100 Canada Nephrology Drugs Market, by End User, 2023-2030 (US$ Mn)

TABLE 101 Mexico Nephrology Drugs Market, by Type, 2017-2022 (US$ Mn)

TABLE 102 Mexico Nephrology Drugs Market, by Type, 2023-2030 (US$ Mn)

TABLE 103 Mexico Nephrology Drugs Market, by Product, 2017-2022 (US$ Mn)

TABLE 104 Mexico Nephrology Drugs Market, by Product, 2023-2030 (US$ Mn)

TABLE 105 Mexico Nephrology Drugs Market, by Application, 2017-2022 (US$ Mn)

TABLE 106 Mexico Nephrology Drugs Market, by Application, 2023-2030 (US$ Mn)

TABLE 107 Mexico Nephrology Drugs Market, by Price Range, By Region, 2017-2022 (US$ Mn)

TABLE 108 Mexico Nephrology Drugs Market, by Price Range, By Region, 2023-2030 (US$ Mn)

TABLE 109 Mexico Nephrology Drugs Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 110 Mexico Nephrology Drugs Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 111 Mexico Nephrology Drugs Market, by End User, 2017-2022 (US$ Mn)

TABLE 112 Mexico Nephrology Drugs Market, by End User, 2023-2030 (US$ Mn)

TABLE 113 Europe Nephrology Drugs Market, by Type, 2017-2022 (US$ Mn)

TABLE 114 Europe Nephrology Drugs Market, by Type, 2023-2030 (US$ Mn)

TABLE 115 Europe Nephrology Drugs Market, by Product, 2017-2022 (US$ Mn)

TABLE 116 Europe Nephrology Drugs Market, by Product, 2023-2030 (US$ Mn)

TABLE 117 Europe Nephrology Drugs Market, by Application, 2017-2022 (US$ Mn)

TABLE 118 Europe Nephrology Drugs Market, by Application, 2023-2030 (US$ Mn)

TABLE 119 Europe Nephrology Drugs Market, by Price Range, By Region, 2017-2022 (US$ Mn)

TABLE 120 Europe Nephrology Drugs Market, by Price Range, By Region, 2023-2030 (US$ Mn)

TABLE 121 Europe Nephrology Drugs Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 122 Europe Nephrology Drugs Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 123 Europe Nephrology Drugs Market, by End User, 2017-2022 (US$ Mn)

TABLE 124 Europe Nephrology Drugs Market, by End User, 2023-2030 (US$ Mn)

TABLE 125 Europe Nephrology Drugs Market, by Country, 2017-2022 (US$ Mn)

TABLE 126 Europe Nephrology Drugs Market, by Country, 2023-2030 (US$ Mn)

TABLE 127 Germany Nephrology Drugs Market, by Type, 2017-2022 (US$ Mn)

TABLE 128 Germany Nephrology Drugs Market, by Type, 2023-2030 (US$ Mn)

TABLE 129 Germany Nephrology Drugs Market, by Product, 2017-2022 (US$ Mn)

TABLE 130 Germany Nephrology Drugs Market, by Product, 2023-2030 (US$ Mn)

TABLE 131 Germany Nephrology Drugs Market, by Application, 2017-2022 (US$ Mn)

TABLE 132 Germany Nephrology Drugs Market, by Application, 2023-2030 (US$ Mn)

TABLE 133 Germany Nephrology Drugs Market, by Price Range, By Region, 2017-2022 (US$ Mn)

TABLE 134 Germany Nephrology Drugs Market, by Price Range, By Region, 2023-2030 (US$ Mn)

TABLE 135 Germany Nephrology Drugs Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 136 Germany Nephrology Drugs Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 137 Germany Nephrology Drugs Market, by End User, 2017-2022 (US$ Mn)

TABLE 138 Germany Nephrology Drugs Market, by End User, 2023-2030 (US$ Mn)

TABLE 139 France Nephrology Drugs Market, by Type, 2017-2022 (US$ Mn)

TABLE 140 France Nephrology Drugs Market, by Type, 2023-2030 (US$ Mn)

TABLE 141 France Nephrology Drugs Market, by Product, 2017-2022 (US$ Mn)

TABLE 142 France Nephrology Drugs Market, by Product, 2023-2030 (US$ Mn)

TABLE 143 France Nephrology Drugs Market, by Application, 2017-2022 (US$ Mn)

TABLE 144 France Nephrology Drugs Market, by Application, 2023-2030 (US$ Mn)

TABLE 145 France Nephrology Drugs Market, by Price Range, By Region, 2017-2022 (US$ Mn)

TABLE 146 France Nephrology Drugs Market, by Price Range, By Region, 2023-2030 (US$ Mn)

TABLE 147 France Nephrology Drugs Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 148 France Nephrology Drugs Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 149 France Nephrology Drugs Market, by End User, 2017-2022 (US$ Mn)

TABLE 150 France Nephrology Drugs Market, by End User, 2023-2030 (US$ Mn)

TABLE 151 United Kingdom Nephrology Drugs Market, by Type, 2017-2022 (US$ Mn)

TABLE 152 United Kingdom Nephrology Drugs Market, by Type, 2023-2030 (US$ Mn)

TABLE 153 United Kingdom Nephrology Drugs Market, by Product, 2017-2022 (US$ Mn)

TABLE 154 United Kingdom Nephrology Drugs Market, by Product, 2023-2030 (US$ Mn)

TABLE 155 United Kingdom Nephrology Drugs Market, by Application, 2017-2022 (US$ Mn)

TABLE 156 United Kingdom Nephrology Drugs Market, by Application, 2023-2030 (US$ Mn)

TABLE 157 United Kingdom Nephrology Drugs Market, by Price Range, By Region, 2017-2022 (US$ Mn)

TABLE 158 United Kingdom Nephrology Drugs Market, by Price Range, By Region, 2023-2030 (US$ Mn)

TABLE 159 United Kingdom Nephrology Drugs Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 160 United Kingdom Nephrology Drugs Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 161 United Kingdom Nephrology Drugs Market, by End User, 2017-2022 (US$ Mn)

TABLE 162 United Kingdom Nephrology Drugs Market, by End User, 2023-2030 (US$ Mn)

TABLE 163 Italy Nephrology Drugs Market, by Type, 2017-2022 (US$ Mn)

TABLE 164 Italy Nephrology Drugs Market, by Type, 2023-2030 (US$ Mn)

TABLE 165 Italy Nephrology Drugs Market, by Product, 2017-2022 (US$ Mn)

TABLE 166 Italy Nephrology Drugs Market, by Product, 2023-2030 (US$ Mn)

TABLE 167 Italy Nephrology Drugs Market, by Application, 2017-2022 (US$ Mn)

TABLE 168 Italy Nephrology Drugs Market, by Application, 2023-2030 (US$ Mn)

TABLE 169 Italy Nephrology Drugs Market, by Price Range, By Region, 2017-2022 (US$ Mn)

TABLE 170 Italy Nephrology Drugs Market, by Price Range, By Region, 2023-2030 (US$ Mn)

TABLE 171 Italy Nephrology Drugs Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 172 Italy Nephrology Drugs Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 173 Italy Nephrology Drugs Market, by End User, 2017-2022 (US$ Mn)

TABLE 174 Italy Nephrology Drugs Market, by End User, 2023-2030 (US$ Mn)

TABLE 175 Spain Nephrology Drugs Market, by Type, 2017-2022 (US$ Mn)

TABLE 176 Spain Nephrology Drugs Market, by Type, 2023-2030 (US$ Mn)

TABLE 177 Spain Nephrology Drugs Market, by Product, 2017-2022 (US$ Mn)

TABLE 178 Spain Nephrology Drugs Market, by Product, 2023-2030 (US$ Mn)

TABLE 179 Spain Nephrology Drugs Market, by Application, 2017-2022 (US$ Mn)

TABLE 180 Spain Nephrology Drugs Market, by Application, 2023-2030 (US$ Mn)

TABLE 181 Spain Nephrology Drugs Market, by Price Range, By Region, 2017-2022 (US$ Mn)

TABLE 182 Spain Nephrology Drugs Market, by Price Range, By Region, 2023-2030 (US$ Mn)

TABLE 183 Spain Nephrology Drugs Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 184 Spain Nephrology Drugs Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 185 Spain Nephrology Drugs Market, by End User, 2017-2022 (US$ Mn)

TABLE 186 Spain Nephrology Drugs Market, by End User, 2023-2030 (US$ Mn)

TABLE 187 Benelux Nephrology Drugs Market, by Type, 2017-2022 (US$ Mn)

TABLE 188 Benelux Nephrology Drugs Market, by Type, 2023-2030 (US$ Mn)

TABLE 189 Benelux Nephrology Drugs Market, by Product, 2017-2022 (US$ Mn)

TABLE 190 Benelux Nephrology Drugs Market, by Product, 2023-2030 (US$ Mn)

TABLE 191 Benelux Nephrology Drugs Market, by Application, 2017-2022 (US$ Mn)

TABLE 192 Benelux Nephrology Drugs Market, by Application, 2023-2030 (US$ Mn)

TABLE 193 Benelux Nephrology Drugs Market, by Price Range, By Region, 2017-2022 (US$ Mn)

TABLE 194 Benelux Nephrology Drugs Market, by Price Range, By Region, 2023-2030 (US$ Mn)

TABLE 195 Benelux Nephrology Drugs Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 196 Benelux Nephrology Drugs Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 197 Benelux Nephrology Drugs Market, by End User, 2017-2022 (US$ Mn)

TABLE 198 Benelux Nephrology Drugs Market, by End User, 2023-2030 (US$ Mn)

TABLE 199 Russia Nephrology Drugs Market, by Type, 2017-2022 (US$ Mn)

TABLE 200 Russia Nephrology Drugs Market, by Type, 2023-2030 (US$ Mn)

TABLE 201 Russia Nephrology Drugs Market, by Product, 2017-2022 (US$ Mn)

TABLE 202 Russia Nephrology Drugs Market, by Product, 2023-2030 (US$ Mn)

TABLE 203 Russia Nephrology Drugs Market, by Application, 2017-2022 (US$ Mn)

TABLE 204 Russia Nephrology Drugs Market, by Application, 2023-2030 (US$ Mn)

TABLE 205 Russia Nephrology Drugs Market, by Price Range, By Region, 2017-2022 (US$ Mn)

TABLE 206 Russia Nephrology Drugs Market, by Price Range, By Region, 2023-2030 (US$ Mn)

TABLE 207 Russia Nephrology Drugs Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 208 Russia Nephrology Drugs Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 209 Russia Nephrology Drugs Market, by End User, 2017-2022 (US$ Mn)

TABLE 210 Russia Nephrology Drugs Market, by End User, 2023-2030 (US$ Mn)

TABLE 211 Rest of Europe Nephrology Drugs Market, by Type, 2017-2022 (US$ Mn)

TABLE 212 Rest of Europe Nephrology Drugs Market, by Type, 2023-2030 (US$ Mn)

TABLE 213 Rest of Europe Nephrology Drugs Market, by Product, 2017-2022 (US$ Mn)

TABLE 214 Rest of Europe Nephrology Drugs Market, by Product, 2023-2030 (US$ Mn)

TABLE 215 Rest of Europe Nephrology Drugs Market, by Application, 2017-2022 (US$ Mn)

TABLE 216 Rest of Europe Nephrology Drugs Market, by Application, 2023-2030 (US$ Mn)

TABLE 217 Rest of Europe Nephrology Drugs Market, by Price Range, By Region, 2017-2022 (US$ Mn)

TABLE 218 Rest of Europe Nephrology Drugs Market, by Price Range, By Region, 2023-2030 (US$ Mn)

TABLE 219 Rest of Europe Nephrology Drugs Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 220 Rest of Europe Nephrology Drugs Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 221 Rest of Europe Nephrology Drugs Market, by End User, 2017-2022 (US$ Mn)

TABLE 222 Rest of Europe Nephrology Drugs Market, by End User, 2023-2030 (US$ Mn)

TABLE 223 Asia Pacific Nephrology Drugs Market, by Type, 2017-2022 (US$ Mn)

TABLE 224 Asia Pacific Nephrology Drugs Market, by Type, 2023-2030 (US$ Mn)

TABLE 225 Asia Pacific Nephrology Drugs Market, by Product, 2017-2022 (US$ Mn)

TABLE 226 Asia Pacific Nephrology Drugs Market, by Product, 2023-2030 (US$ Mn)

TABLE 227 Asia Pacific Nephrology Drugs Market, by Application, 2017-2022 (US$ Mn)

TABLE 228 Asia Pacific Nephrology Drugs Market, by Application, 2023-2030 (US$ Mn)

TABLE 229 Asia Pacific Nephrology Drugs Market, by Price Range, By Region, 2017-2022 (US$ Mn)

TABLE 230 Asia Pacific Nephrology Drugs Market, by Price Range, By Region, 2023-2030 (US$ Mn)

TABLE 231 Asia Pacific Nephrology Drugs Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 232 Asia Pacific Nephrology Drugs Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 233 Asia Pacific Nephrology Drugs Market, by End User, 2017-2022 (US$ Mn)

TABLE 234 Asia Pacific Nephrology Drugs Market, by End User, 2023-2030 (US$ Mn)

TABLE 235 China Nephrology Drugs Market, by Type, 2017-2022 (US$ Mn)

TABLE 236 China Nephrology Drugs Market, by Type, 2023-2030 (US$ Mn)

TABLE 237 China Nephrology Drugs Market, by Product, 2017-2022 (US$ Mn)

TABLE 238 China Nephrology Drugs Market, by Product, 2023-2030 (US$ Mn)

TABLE 239 China Nephrology Drugs Market, by Application, 2017-2022 (US$ Mn)

TABLE 240 China Nephrology Drugs Market, by Application, 2023-2030 (US$ Mn)

TABLE 241 China Nephrology Drugs Market, by Price Range, By Region, 2017-2022 (US$ Mn)

TABLE 242 China Nephrology Drugs Market, by Price Range, By Region, 2023-2030 (US$ Mn)

TABLE 243 China Nephrology Drugs Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 244 China Nephrology Drugs Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 245 China Nephrology Drugs Market, by End User, 2017-2022 (US$ Mn)

TABLE 246 China Nephrology Drugs Market, by End User, 2023-2030 (US$ Mn)

TABLE 247 Japan Nephrology Drugs Market, by Type, 2017-2022 (US$ Mn)

TABLE 248 Japan Nephrology Drugs Market, by Type, 2023-2030 (US$ Mn)

TABLE 249 Japan Nephrology Drugs Market, by Product, 2017-2022 (US$ Mn)

TABLE 250 Japan Nephrology Drugs Market, by Product, 2023-2030 (US$ Mn)

TABLE 251 Japan Nephrology Drugs Market, by Application, 2017-2022 (US$ Mn)

TABLE 252 Japan Nephrology Drugs Market, by Application, 2023-2030 (US$ Mn)

TABLE 253 Japan Nephrology Drugs Market, by Price Range, By Region, 2017-2022 (US$ Mn)

TABLE 254 Japan Nephrology Drugs Market, by Price Range, By Region, 2023-2030 (US$ Mn)

TABLE 255 Japan Nephrology Drugs Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 256 Japan Nephrology Drugs Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 257 Japan Nephrology Drugs Market, by End User, 2017-2022 (US$ Mn)

TABLE 258 Japan Nephrology Drugs Market, by End User, 2023-2030 (US$ Mn)

TABLE 259 India Nephrology Drugs Market, by Type, 2017-2022 (US$ Mn)

TABLE 260 India Nephrology Drugs Market, by Type, 2023-2030 (US$ Mn)

TABLE 261 India Nephrology Drugs Market, by Product, 2017-2022 (US$ Mn)

TABLE 262 India Nephrology Drugs Market, by Product, 2023-2030 (US$ Mn)

TABLE 263 India Nephrology Drugs Market, by Application, 2017-2022 (US$ Mn)

TABLE 264 India Nephrology Drugs Market, by Application, 2023-2030 (US$ Mn)

TABLE 265 India Nephrology Drugs Market, by Price Range, By Region, 2017-2022 (US$ Mn)

TABLE 266 India Nephrology Drugs Market, by Price Range, By Region, 2023-2030 (US$ Mn)

TABLE 267 India Nephrology Drugs Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 268 India Nephrology Drugs Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 269 India Nephrology Drugs Market, by End User, 2017-2022 (US$ Mn)

TABLE 270 India Nephrology Drugs Market, by End User, 2023-2030 (US$ Mn)

TABLE 271 South Korea Nephrology Drugs Market, by Type, 2017-2022 (US$ Mn)

TABLE 272 South Korea Nephrology Drugs Market, by Type, 2023-2030 (US$ Mn)

TABLE 273 South Korea Nephrology Drugs Market, by Product, 2017-2022 (US$ Mn)

TABLE 274 South Korea Nephrology Drugs Market, by Product, 2023-2030 (US$ Mn)

TABLE 275 South Korea Nephrology Drugs Market, by Application, 2017-2022 (US$ Mn)

TABLE 276 South Korea Nephrology Drugs Market, by Application, 2023-2030 (US$ Mn)

TABLE 277 South Korea Nephrology Drugs Market, by Price Range, By Region, 2017-2022 (US$ Mn)

TABLE 278 South Korea Nephrology Drugs Market, by Price Range, By Region, 2023-2030 (US$ Mn)

TABLE 279 South Korea Nephrology Drugs Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 280 South Korea Nephrology Drugs Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 281 South Korea Nephrology Drugs Market, by End User, 2017-2022 (US$ Mn)

TABLE 282 South Korea Nephrology Drugs Market, by End User, 2023-2030 (US$ Mn)

TABLE 283 South-East Asia Nephrology Drugs Market, by Type, 2017-2022 (US$ Mn)

TABLE 284 South-East Asia Nephrology Drugs Market, by Type, 2023-2030 (US$ Mn)

TABLE 285 South-East Asia Nephrology Drugs Market, by Product, 2017-2022 (US$ Mn)

TABLE 286 South-East Asia Nephrology Drugs Market, by Product, 2023-2030 (US$ Mn)

TABLE 287 South-East Asia Nephrology Drugs Market, by Application, 2017-2022 (US$ Mn)

TABLE 288 South-East Asia Nephrology Drugs Market, by Application, 2023-2030 (US$ Mn)

TABLE 289 South-East Asia Nephrology Drugs Market, by Price Range, By Region, 2017-2022 (US$ Mn)

TABLE 290 South-East Asia Nephrology Drugs Market, by Price Range, By Region, 2023-2030 (US$ Mn)

TABLE 291 South-East Asia Nephrology Drugs Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 292 South-East Asia Nephrology Drugs Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 293 South-East Asia Nephrology Drugs Market, by End User, 2017-2022 (US$ Mn)

TABLE 294 South-East Asia Nephrology Drugs Market, by End User, 2023-2030 (US$ Mn)

TABLE 295 Rest of Asia Pacific Nephrology Drugs Market, by Type, 2017-2022 (US$ Mn)

TABLE 296 Rest of Asia Pacific Nephrology Drugs Market, by Type, 2023-2030 (US$ Mn)

TABLE 297 Rest of Asia Pacific Nephrology Drugs Market, by Product, 2017-2022 (US$ Mn)

TABLE 298 Rest of Asia Pacific Nephrology Drugs Market, by Product, 2023-2030 (US$ Mn)

TABLE 299 Rest of Asia Pacific Nephrology Drugs Market, by Application, 2017-2022 (US$ Mn)

TABLE 300 Rest of Asia Pacific Nephrology Drugs Market, by Application, 2023-2030 (US$ Mn)

TABLE 301 Rest of Asia Pacific Nephrology Drugs Market, by Price Range, By Region, 2017-2022 (US$ Mn)

TABLE 302 Rest of Asia Pacific Nephrology Drugs Market, by Price Range, By Region, 2023-2030 (US$ Mn)

TABLE 303 Rest of Asia Pacific Nephrology Drugs Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 304 Rest of Asia Pacific Nephrology Drugs Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 305 Rest of Asia Pacific Nephrology Drugs Market, by End User, 2017-2022 (US$ Mn)

TABLE 306 Rest of Asia Pacific Nephrology Drugs Market, by End User, 2023-2030 (US$ Mn)

TABLE 307 Latin America Nephrology Drugs Market, by Type, 2017-2022 (US$ Mn)

TABLE 308 Latin America Nephrology Drugs Market, by Type, 2023-2030 (US$ Mn)

TABLE 309 Latin America Nephrology Drugs Market, by Product, 2017-2022 (US$ Mn)

TABLE 310 Latin America Nephrology Drugs Market, by Product, 2023-2030 (US$ Mn)

TABLE 311 Latin America Nephrology Drugs Market, by Application, 2017-2022 (US$ Mn)

TABLE 312 Latin America Nephrology Drugs Market, by Application, 2023-2030 (US$ Mn)

TABLE 313 Latin America Nephrology Drugs Market, by Price Range, By Region, 2017-2022 (US$ Mn)

TABLE 314 Latin America Nephrology Drugs Market, by Price Range, By Region, 2023-2030 (US$ Mn)

TABLE 315 Latin America Nephrology Drugs Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 316 Latin America Nephrology Drugs Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 317 Latin America Nephrology Drugs Market, by End User, 2017-2022 (US$ Mn)

TABLE 318 Latin America Nephrology Drugs Market, by End User, 2023-2030 (US$ Mn)

TABLE 319 Brazil Nephrology Drugs Market, by Type, 2017-2022 (US$ Mn)

TABLE 320 Brazil Nephrology Drugs Market, by Type, 2023-2030 (US$ Mn)

TABLE 321 Brazil Nephrology Drugs Market, by Product, 2017-2022 (US$ Mn)

TABLE 322 Brazil Nephrology Drugs Market, by Product, 2023-2030 (US$ Mn)

TABLE 323 Brazil Nephrology Drugs Market, by Application, 2017-2022 (US$ Mn)

TABLE 324 Brazil Nephrology Drugs Market, by Application, 2023-2030 (US$ Mn)

TABLE 325 Brazil Nephrology Drugs Market, by Price Range, By Region, 2017-2022 (US$ Mn)

TABLE 326 Brazil Nephrology Drugs Market, by Price Range, By Region, 2023-2030 (US$ Mn)

TABLE 327 Brazil Nephrology Drugs Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 328 Brazil Nephrology Drugs Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 329 Brazil Nephrology Drugs Market, by End User, 2017-2022 (US$ Mn)

TABLE 330 Brazil Nephrology Drugs Market, by End User, 2023-2030 (US$ Mn)

TABLE 331 Argentina Nephrology Drugs Market, by Type, 2017-2022 (US$ Mn)

TABLE 332 Argentina Nephrology Drugs Market, by Type, 2023-2030 (US$ Mn)

TABLE 333 Argentina Nephrology Drugs Market, by Product, 2017-2022 (US$ Mn)

TABLE 334 Argentina Nephrology Drugs Market, by Product, 2023-2030 (US$ Mn)

TABLE 335 Argentina Nephrology Drugs Market, by Application, 2017-2022 (US$ Mn)

TABLE 336 Argentina Nephrology Drugs Market, by Application, 2023-2030 (US$ Mn)

TABLE 337 Argentina Nephrology Drugs Market, by Price Range, By Region, 2017-2022 (US$ Mn)

TABLE 338 Argentina Nephrology Drugs Market, by Price Range, By Region, 2023-2030 (US$ Mn)

TABLE 339 Argentina Nephrology Drugs Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 340 Argentina Nephrology Drugs Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 341 Argentina Nephrology Drugs Market, by End User, 2017-2022 (US$ Mn)

TABLE 342 Argentina Nephrology Drugs Market, by End User, 2023-2030 (US$ Mn)

TABLE 343 Rest of Latin America Nephrology Drugs Market, by Type, 2017-2022 (US$ Mn)

TABLE 344 Rest of Latin America Nephrology Drugs Market, by Type, 2023-2030 (US$ Mn)

TABLE 345 Rest of Latin America Nephrology Drugs Market, by Product, 2017-2022 (US$ Mn)

TABLE 346 Rest of Latin America Nephrology Drugs Market, by Product, 2023-2030 (US$ Mn)

TABLE 347 Rest of Latin America Nephrology Drugs Market, by Application, 2017-2022 (US$ Mn)

TABLE 348 Rest of Latin America Nephrology Drugs Market, by Application, 2023-2030 (US$ Mn)

TABLE 349 Rest of Latin America Nephrology Drugs Market, by Price Range, By Region, 2017-2022 (US$ Mn)

TABLE 350 Rest of Latin America Nephrology Drugs Market, by Price Range, By Region, 2023-2030 (US$ Mn)

TABLE 351 Rest of Latin America Nephrology Drugs Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 352 Rest of Latin America Nephrology Drugs Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 353 Rest of Latin America Nephrology Drugs Market, by End User, 2017-2022 (US$ Mn)

TABLE 354 Rest of Latin America Nephrology Drugs Market, by End User, 2023-2030 (US$ Mn)

TABLE 355 Middle East Nephrology Drugs Market, by Type, 2017-2022 (US$ Mn)

TABLE 356 Middle East Nephrology Drugs Market, by Type, 2023-2030 (US$ Mn)

TABLE 357 Middle East Nephrology Drugs Market, by Product, 2017-2022 (US$ Mn)

TABLE 358 Middle East Nephrology Drugs Market, by Product, 2023-2030 (US$ Mn)

TABLE 359 Middle East Nephrology Drugs Market, by Application, 2017-2022 (US$ Mn)

TABLE 360 Middle East Nephrology Drugs Market, by Application, 2023-2030 (US$ Mn)

TABLE 361 Middle East Nephrology Drugs Market, by Price Range, By Region, 2017-2022 (US$ Mn)

TABLE 362 Middle East Nephrology Drugs Market, by Price Range, By Region, 2023-2030 (US$ Mn)

TABLE 363 Middle East Nephrology Drugs Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 364 Middle East Nephrology Drugs Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 365 Middle East Nephrology Drugs Market, by End User, 2017-2022 (US$ Mn)

TABLE 366 Middle East Nephrology Drugs Market, by End User, 2023-2030 (US$ Mn)

TABLE 367 UAE Nephrology Drugs Market, by Type, 2017-2022 (US$ Mn)

TABLE 368 UAE Nephrology Drugs Market, by Type, 2023-2030 (US$ Mn)

TABLE 369 UAE Nephrology Drugs Market, by Product, 2017-2022 (US$ Mn)

TABLE 370 UAE Nephrology Drugs Market, by Product, 2023-2030 (US$ Mn)

TABLE 371 UAE Nephrology Drugs Market, by Application, 2017-2022 (US$ Mn)

TABLE 372 UAE Nephrology Drugs Market, by Application, 2023-2030 (US$ Mn)

TABLE 373 UAE Nephrology Drugs Market, by Price Range, By Region, 2017-2022 (US$ Mn)

TABLE 374 UAE Nephrology Drugs Market, by Price Range, By Region, 2023-2030 (US$ Mn)

TABLE 375 UAE Nephrology Drugs Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 376 UAE Nephrology Drugs Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 377 UAE Nephrology Drugs Market, by End User, 2017-2022 (US$ Mn)

TABLE 378 UAE Nephrology Drugs Market, by End User, 2023-2030 (US$ Mn)

TABLE 379 Saudi Arabia Nephrology Drugs Market, by Type, 2017-2022 (US$ Mn)

TABLE 380 Saudi Arabia Nephrology Drugs Market, by Type, 2023-2030 (US$ Mn)

TABLE 381 Saudi Arabia Nephrology Drugs Market, by Product, 2017-2022 (US$ Mn)

TABLE 382 Saudi Arabia Nephrology Drugs Market, by Product, 2023-2030 (US$ Mn)

TABLE 383 Saudi Arabia Nephrology Drugs Market, by Application, 2017-2022 (US$ Mn)

TABLE 384 Saudi Arabia Nephrology Drugs Market, by Application, 2023-2030 (US$ Mn)

TABLE 385 Saudi Arabia Nephrology Drugs Market, by Price Range, By Region, 2017-2022 (US$ Mn)

TABLE 386 Saudi Arabia Nephrology Drugs Market, by Price Range, By Region, 2023-2030 (US$ Mn)

TABLE 387 Saudi Arabia Nephrology Drugs Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 388 Saudi Arabia Nephrology Drugs Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 389 Saudi Arabia Nephrology Drugs Market, by End User, 2017-2022 (US$ Mn)

TABLE 390 Saudi Arabia Nephrology Drugs Market, by End User, 2023-2030 (US$ Mn)

TABLE 391 Rest of Middle East Nephrology Drugs Market, by Type, 2017-2022 (US$ Mn)

TABLE 392 Rest of Middle East Nephrology Drugs Market, by Type, 2023-2030 (US$ Mn)

TABLE 393 Rest of Middle East Nephrology Drugs Market, by Product, 2017-2022 (US$ Mn)

TABLE 394 Rest of Middle East Nephrology Drugs Market, by Product, 2023-2030 (US$ Mn)

TABLE 395 Rest of Middle East Nephrology Drugs Market, by Application, 2017-2022 (US$ Mn)

TABLE 396 Rest of Middle East Nephrology Drugs Market, by Application, 2023-2030 (US$ Mn)

TABLE 397 Rest of Middle East Nephrology Drugs Market, by Price Range, By Region, 2017-2022 (US$ Mn)

TABLE 398 Rest of Middle East Nephrology Drugs Market, by Price Range, By Region, 2023-2030 (US$ Mn)

TABLE 399 Rest of Middle East Nephrology Drugs Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 400 Rest of Middle East Nephrology Drugs Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 401 Rest of Middle East Nephrology Drugs Market, by End User, 2017-2022 (US$ Mn)

TABLE 402 Rest of Middle East Nephrology Drugs Market, by End User, 2023-2030 (US$ Mn)

TABLE 403 Africa Nephrology Drugs Market, by Type, 2017-2022 (US$ Mn)

TABLE 404 Africa Nephrology Drugs Market, by Type, 2023-2030 (US$ Mn)

TABLE 405 Africa Nephrology Drugs Market, by Product, 2017-2022 (US$ Mn)

TABLE 406 Africa Nephrology Drugs Market, by Product, 2023-2030 (US$ Mn)

TABLE 407 Africa Nephrology Drugs Market, by Application, 2017-2022 (US$ Mn)

TABLE 408 Africa Nephrology Drugs Market, by Application, 2023-2030 (US$ Mn)

TABLE 409 Africa Nephrology Drugs Market, by Price Range, By Region, 2017-2022 (US$ Mn)

TABLE 410 Africa Nephrology Drugs Market, by Price Range, By Region, 2023-2030 (US$ Mn)

TABLE 411 Africa Nephrology Drugs Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 412 Africa Nephrology Drugs Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 413 Africa Nephrology Drugs Market, by End User, 2017-2022 (US$ Mn)

TABLE 414 Africa Nephrology Drugs Market, by End User, 2023-2030 (US$ Mn)

TABLE 415 South Africa Nephrology Drugs Market, by Type, 2017-2022 (US$ Mn)

TABLE 416 South Africa Nephrology Drugs Market, by Type, 2023-2030 (US$ Mn)

TABLE 417 South Africa Nephrology Drugs Market, by Product, 2017-2022 (US$ Mn)

TABLE 418 South Africa Nephrology Drugs Market, by Product, 2023-2030 (US$ Mn)

TABLE 419 South Africa Nephrology Drugs Market, by Application, 2017-2022 (US$ Mn)

TABLE 420 South Africa Nephrology Drugs Market, by Application, 2023-2030 (US$ Mn)

TABLE 421 South Africa Nephrology Drugs Market, by Price Range, By Region, 2017-2022 (US$ Mn)

TABLE 422 South Africa Nephrology Drugs Market, by Price Range, By Region, 2023-2030 (US$ Mn)

TABLE 423 South Africa Nephrology Drugs Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 424 South Africa Nephrology Drugs Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 425 South Africa Nephrology Drugs Market, by End User, 2017-2022 (US$ Mn)

TABLE 426 South Africa Nephrology Drugs Market, by End User, 2023-2030 (US$ Mn)

TABLE 427 Egypt Nephrology Drugs Market, by Type, 2017-2022 (US$ Mn)

TABLE 428 Egypt Nephrology Drugs Market, by Type, 2023-2030 (US$ Mn)

TABLE 429 Egypt Nephrology Drugs Market, by Product, 2017-2022 (US$ Mn)

TABLE 430 Egypt Nephrology Drugs Market, by Product, 2023-2030 (US$ Mn)

TABLE 431 Egypt Nephrology Drugs Market, by Application, 2017-2022 (US$ Mn)

TABLE 432 Egypt Nephrology Drugs Market, by Application, 2023-2030 (US$ Mn)

TABLE 433 Egypt Nephrology Drugs Market, by Price Range, By Region, 2017-2022 (US$ Mn)

TABLE 434 Egypt Nephrology Drugs Market, by Price Range, By Region, 2023-2030 (US$ Mn)

TABLE 435 Egypt Nephrology Drugs Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 436 Egypt Nephrology Drugs Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 437 Egypt Nephrology Drugs Market, by End User, 2017-2022 (US$ Mn)

TABLE 438 Egypt Nephrology Drugs Market, by End User, 2023-2030 (US$ Mn)

TABLE 439 Rest of Africa Nephrology Drugs Market, by Type, 2017-2022 (US$ Mn)

TABLE 440 Rest of Africa Nephrology Drugs Market, by Type, 2023-2030 (US$ Mn)

TABLE 441 Rest of Africa Nephrology Drugs Market, by Product, 2017-2022 (US$ Mn)

TABLE 442 Rest of Africa Nephrology Drugs Market, by Product, 2023-2030 (US$ Mn)

TABLE 443 Rest of Africa Nephrology Drugs Market, by Application, 2017-2022 (US$ Mn)

TABLE 444 Rest of Africa Nephrology Drugs Market, by Application, 2023-2030 (US$ Mn)

TABLE 445 Rest of Africa Nephrology Drugs Market, by Price Range, By Region, 2017-2022 (US$ Mn)

TABLE 446 Rest of Africa Nephrology Drugs Market, by Price Range, By Region, 2023-2030 (US$ Mn)

TABLE 447 Rest of Africa Nephrology Drugs Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 448 Rest of Africa Nephrology Drugs Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 449 Rest of Africa Nephrology Drugs Market, by End User, 2017-2022 (US$ Mn)

TABLE 450 Rest of Africa Nephrology Drugs Market, by End User, 2023-2030 (US$ Mn)

Frequently asked questions

What is the current size of the global nephrology drugs market?

The global nephrology drugs market was valued at USD 16248.5 Million in 2022.

What is the expected growth rate of the nephrology drugs market between 2023 and 2030?

The nephrology drugs market is expected to grow at a CAGR of 5.9% between 2023 and 2030, reaching USD 25702.8 Million in 2030.

Which segment is leading the market share in terms of product?

Immunosuppressants are the leading segment by product, holding over 25% share in value in 2022.

Which application segment governs the global demand for nephrology drugs?

The chronic kidney disease (CKD) segment governs the global demand for nephrology drugs, holding a massive market share of over 60% in 2022.

Which distribution channel segment will post the highest CAGR in the forecast period?

The specialized nephrology clinics segment will post the highest CAGR over the projection period.

Which region is fueling the growth of the nephrology drugs industry?

North America is fueling the rapid growth of the nephrology drugs industry, with over one-third of its share in 2022.

Who are the main players in the global nephrology drugs market?

The top players include AstraZeneca, Pfizer Inc, Amgen Inc, FibroGen Inc, GlaxoSmithKline Plc, AbbVie Inc, Akebia Therapeutics Inc, Teva Pharmaceutical Industries, Johnson & Johnson Inc, F. Hoffmann-La Roche, and Others.

What are the major market drivers of the nephrology drugs industry?

The major market drivers are the rising prevalence of kidney diseases, particularly due to risk factors like diabetes and hypertension, and advancements in pharmaceutical research leading to innovative drug therapies.

What are the major market restraints of the nephrology drugs industry?

The major market restraints are the high cost of nephrology drugs, limited awareness and delayed diagnosis of kidney diseases, and the emergence of drug-resistant strains of kidney-related pathogens.

What are the major market opportunities in the nephrology drugs industry?

The major market opportunities are the expansion of remote patient monitoring and telemedicine, advancements in precision medicine and regenerative therapies, and the growing emphasis on disease prevention and early intervention strategies.

Rotator Cuff Injury Treatment Market

Published:
Report ID: 36567

Aspergillosis Treatment Market

Published:
Report ID: 2106

Middle East And Africa Female Hygiene Products Market

Published:
Report ID: 8484

Therapeutic Monoclonal Antibodies Market

Published:
Report ID: 11175

Prostate Cancer Market

Published:
Report ID: 36273

Antineoplastic Agents Market

Published:
Report ID: 36065

US Retail Pharmacy Market

Published:
Report ID: 32801

OTC Vitamins Dietary Supplements Market

Published:
Report ID: 35994

Liposomes Market

Published:
Report ID: 35888

UK Iron Supplement Market

Published:
Report ID: 35709

U.S. Iron Supplement Market

Published:
Report ID: 35688

Malignant Ascites Market

Published:
Report ID: 11184

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN